Skip to main content

Advertisement

SpringerLink
Log in

Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation

  • Engineering and Nano-engineering Approaches for Medical Devices
  • Published:
Journal of Materials Science: Materials in Medicine Aims and scope Submit manuscript

Abstract

Liposomal carriers for topical drug delivery have been studied since the 1980s and have evoked a considerable interest. However, the conventional liposomes do not deeply penetrate into the skin and remain confined to the outer layer of SC. In order to increase skin targeting of ketoconazole (KCZ), a hydrophobic broad-spectrum antifungal agent, this study describes novel lipid vesicles as nano-carriers for topical delivery. In this paper, lipid vesicular systems including conventional liposomes (CL), ethosomes, deformable liposomes (DL) and ethanol-containing deformable liposomes (DEL) were prepared as nano-carriers for KCZ, respectively. Sodium dodecyl sulfate [SDS, 0.08 % (W/V)] was used as edge activator for DL and DEL preparation. Characterization of the vesicles was based on particle size, zeta potential, entrapment efficiency and transmission electron microscopy (TEM). In addition, in vitro permeation profile was obtained using vertical diffusion Franz cells by porcine skin. The in vivo accumulation of KCZ was also evaluated in rat skin. Confocal microscopy was performed to visualize the penetration of fluorescently labeled vesicles into skin. All of the lipid vesicles showed almost spherical structures with low polydispersity index (PDI < 0.3) and nano-metric size (no more than 160 nm). The results demonstrated that DEL dramatically improved both in vitro and in vivo skin deposition compared to the CLs (P < 0.05), which was further confirmed by confocal laser scanning microscopy study. In vivo pharmacodynamic studies showed DEL improved antifungal activity against Candida albicans in shorter duration of time. Therefore, based on present study, the novel nano-carrier DEL capable of enhancing skin target effect and forming a micro drug-depot could serve as an effective skin targeting delivery for KCZ as an anti-fungal agent in local therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Odds FC, Miline LJ, Gentles JC, Hazel Ball E. The activity in vitro and in vivo of a new imidazole antifungal, ketoconazole. J Antimicrob Chemother. 1980;6:97–104.

    Article  Google Scholar 

  2. Custem JV. The antifungal activity of ketoconazole. Am J Med. 1983;74:9–15.

    Google Scholar 

  3. FDA Drug Safety Communications, 2013. FDA limits usage of Nizoral (ketoconazole) oral tablets due to potential fatal liver injury and risk of drug interactions and adrenal gland problems.

  4. Bouwatra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res. 2003;42:1–46.

    Article  Google Scholar 

  5. Schreier H, Bouwatra J. Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Control Release. 1994;30:1–15.

    Article  Google Scholar 

  6. Kirjavainen M, Arto U, Jaaskelainen I, Sobhonen TM, Paronen P, Valjakka-Koskela R, Kiesvaara J, Monkkonen J. Interaction of liposomes with human skin in vitro-The influence of lipid composition and structure. Biochim Biophys Acta. 1996;1304:179–89.

    Article  Google Scholar 

  7. Sinico C, Manconi M, Peppi M, Lai F, Valenti D, Fadda AM. Liposomes as carriers for dermal delivery of tretinon: in vitro evaluation of drug permeation and vesicle-skin interaction. J Control Release. 2005;103:123–36.

    Article  Google Scholar 

  8. Jain S, Tiwary AK, Sapra B, Jain NK. Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS Pharm Sci Tech. 2007;21:E1–9.

    Google Scholar 

  9. Gillet A, Lecomte F, Hubert P, Ducat E, Evrard B, Piel G. Skin penetration behavior of liposomes as a function of their composition. Eur J Pharm Biopharm. 2011;79:43–53.

    Article  Google Scholar 

  10. Qiu Y, Gao Y, Hu K, Li F. Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Control Release. 2008;129:144–50.

    Article  Google Scholar 

  11. Song CK, Balakrishnan P, Shim CK, Chung SJ, Chong S, Kim DD. A novel vesicular carrier, transethosome, for enhanced skin delivery of voriconazole: characterization and in vitro/in vivo evaluation. Colloids Surf B. 2012;92:299–304.

    Article  Google Scholar 

  12. Zheng WS, Fang XQ, Wang LL, Zhang YJ. Preparation and quality assessment of itraconazole transfersomes. Int J Pharm. 2012;436:291–8.

    Article  Google Scholar 

  13. Touitou E, Dayan N, Bergelson L, Godin B. Ethosomes—novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Release. 2000;65:403–18.

    Article  Google Scholar 

  14. Dayan N, Touitou E. Carrrers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposmes. Biomaterials. 2000;21:1879–85.

    Article  Google Scholar 

  15. Dubey V, Mishra D, Dutta T, Saraf M, Jain NK. Dermal and transdermal delivery of an antipsoriatic agent via ethanolic liposomes. J Control Release. 2007;123:148–54.

    Article  Google Scholar 

  16. Verma P, Pharm B, Pharm M, Pathak K. Nanosized ethanolic vesicles loaded with econazole nitrate for the treatment of deep fungal infections through topical gel formulation. Nanomedicine. 2012;8:489–96.

    Article  Google Scholar 

  17. Li G, Fan Y, Fan C, Li X, Wang X, Li M, Liu Y. Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm. 2012;82:49–57.

    Article  Google Scholar 

  18. Pradhan M, Singh D, Singh MR. Novel colloidal carrier for psoriasis: current issues, mechanistic insight and novel delivery approaches. J Control Release. 2013;170:380–95.

    Article  Google Scholar 

  19. Lee EH, Oh A, Kim YK. Effect of edge activators on the formation and transfection efficiency of ultradeformable liposomes. Biomaterials. 2005;26:205–10.

    Article  Google Scholar 

  20. Oh EK, Jin SE, Park JS, Park Y, Kim CK. Retained topical delivery of 5-aminolevulinic acid using cationic ultradeformable liposomes for photodynamic therapy. Eur J Pharm Sci. 2012;44:149–57.

    Article  Google Scholar 

  21. Cevc G, Blume G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gryadients and hydration force. Biochim Biophys Acta. 1992;1104:226–32.

    Article  Google Scholar 

  22. Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm. 2004;260:119–25.

    Article  Google Scholar 

  23. Kombath RV, Minumula SK, Sockalingam A, Subadhra S, Parre S, Reddy RT, David B. Critical issues related to transfersomes-novel vesicular system. Acta Aci Pol Technol Aliment. 2012;11:67–82.

    Google Scholar 

  24. Honeywell-Nguyen PL, de Graaff AM, Groenink HW, Bouwstra JA. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim Biophys Acta. 2002;1573:130–40.

    Article  Google Scholar 

  25. Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol. 2004;123:902–10.

    Article  Google Scholar 

  26. Honeywell-Nguyen PL, Bouwstra JA. Vesicles as a tool for transdermal and dermal delivery. Drug Discov Today. 2005;2:67–74.

    Article  Google Scholar 

  27. Liu D, Hu H, Lin Z, Chen D, Zhu Y, Hou S, Shi X. Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo. J Photochem Photobiol B. 2013;127:8–17.

    Article  Google Scholar 

  28. Gupta PN, et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm. 2005;293:73–82.

    Article  Google Scholar 

  29. Van den Bergh BAI, et al. Elasticity of vesicles assessed by electron spin resonance, electron microscopy and extrusion measurements. Int J Pharm. 2001;217:13–24.

    Article  Google Scholar 

  30. Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies II. Animal models for human skin. Toxicol Appl Pharmacol. 1982;62:481–8.

    Article  Google Scholar 

  31. Sullivan TP, Eaglstein WH, Davis SC, Mertz P. The pig as a model for human wound healing. Wound Repair Regen. 2001;9:66–76.

    Article  Google Scholar 

  32. Eskandar NG, Simovie A, Prestidge CA. Nanoparticle coated submicron emulsions: sustained in vitro release and improved dermal delivery of all-trans-retinol. Pharm Res. 2009;26:1764–73.

    Article  Google Scholar 

  33. Panchagnula R, Desu H, Jain A, Khandavilli S. Effect of lipid bilayer alteration on transdermal delivery of a high-molecular-weight and lipophilic drug: studies with paclitaxel. J Pharm Sci. 2004;93:2177–83.

    Article  Google Scholar 

  34. Howes D, Guy R, Hadgraft J, Heylings J, Hoeck U, Kemper F, et al. Methods for assessing percutaneous absorption: the report and recommendations of ECVAM Workshop 13. Altern Lab Anim. 1996;24:81–106.

    Google Scholar 

  35. Uchida K, Tanaka T, Yamaguchi H. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis. Mircrobiol Immunol. 2003;47:143–6.

    Article  Google Scholar 

  36. Tatsumi Y, Yokoo M, Arika T, Yamaguchi H. In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs. Antimicrob Agents Chemother. 2001;45:1493–9.

    Article  Google Scholar 

  37. El Maghraby GM, Williams AC, Barry BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm. 2004;276:143–61.

    Article  Google Scholar 

  38. El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol. 1999;51:1123–34.

    Article  Google Scholar 

  39. El Maghraby GM, Barry BW, Williams AC. Liposomes and skin: from drug delivery to model membranes. Eur J Pharm Sci. 2008;34:203–22.

    Article  Google Scholar 

  40. El Maghraby GM, Williams AC, Barry BW. Interactions of surfactants (edge activators) and skin penetration enhancers with liposomes. Int J Pharm. 2004;275:143–61.

    Article  Google Scholar 

  41. Prausnita MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–7.

    Article  Google Scholar 

  42. El Maghraby GM, Williams AC, Barry BW. Can drug bearing liposomes penetrate intact skin? J Pharm Pharmacol. 2006;58:415–29.

    Article  Google Scholar 

  43. Touitou E, Godin B, Dayan N, Weiss C, Piliponsky A, Levi-Schaffer F. Intracellular delivery mediated by an ethosomal carrier. Biomaterials. 2001;22:3053–9.

    Article  Google Scholar 

  44. Li G, Fan C, Li X, Liu Y. Preparation and in vitro evaluation of tacrolimus-loaded ethosomes. Sci World J. 2012;2012:1–6.

    Google Scholar 

  45. Valenta C, Janisch M. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids. Int J Pharm. 2003;258:133–9.

    Article  Google Scholar 

  46. Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes influences dermal delivery of substance into skin. Int J Pharm. 2003;258:141–51.

    Article  Google Scholar 

Download references

Acknowledgments

This research was supported partially by the National Basic Research Project (2014CB932200) of the MOST for financial support.

Conflict of interest

The authors report no declarations of interest.

Author information

Authors and Affiliations

  1. Tianjin Key Laboratory of Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, Tianjin, 300072, People’s Republic of China

    Fang Guo, Jinping Wang, Man Ma, Fengping Tan & Nan Li

Authors
  1. Fang Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinping Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Man Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fengping Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Nan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Fengping Tan or Nan Li.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, F., Wang, J., Ma, M. et al. Skin targeted lipid vesicles as novel nano-carrier of ketoconazole: characterization, in vitro and in vivo evaluation. J Mater Sci: Mater Med 26, 175 (2015). https://doi.org/10.1007/s10856-015-5487-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s10856-015-5487-2

Keywords

Search

Navigation